Anti-tumour pharmaceutical composition with angiogenesis inhibitors

摘要

The present invention provides a pharmaceutical composition comprising a VEGF receptor kinase inhibitor in combination with a substance having EGF inhibitory activity. The pharmaceutical composition can be used in a method of treating cancer. The invention also provides kits containing a combination of a preparation comprising a VEGF receptor kinase inhibitor and a preparation comprising a substance having EGF inhibitory activity.